India gears up to produce cheap weight-loss jabsAFP, MUMBAI, IndiaA deluge of weight-loss drugs is set to transform the global fight against obesity as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent expired yesterday. A photograph taken on Tuesday shows obesity doctor and consultant Swati Pradhan explaining the Mounjaro GLP-1 self-injectable device at her clinic in Mumbai, India. Photo: AFPMore than 50 people walk into endocrinologist Nadeem Rais’ office every week seeking weight-loss injections. At least four major firms have already prepared generic semaglutide injections, regulatory filings and compliance documents viewed by AFP show. Some, including Zydus Lifesciences, have announced “Day 1” launches, suggesting generic versions might become available as soon as this weekend in India.

Source: Taipei Times March 20, 2026 16:24 UTC